VCU-Led Research Highlights Semaglutide's Potential for Treating Fatty Liver Disease
May 01, 2025
May 01, 2025
RICHMOND, Virginia, May 1 -- VCU Health, an academic medical center on the forefront of health care, providing patients with treatments and medical technology available, issued the following news release:
* * *
VCU-led research highlights semaglutide's potential for treating fatty liver disease
International study shows drug reverses liver damage in patients.
An international study led by the director of Virginia Commonwealth University� . . .
* * *
VCU-led research highlights semaglutide's potential for treating fatty liver disease
International study shows drug reverses liver damage in patients.
An international study led by the director of Virginia Commonwealth University� . . .